Morningstar US Small Growth Rating $13.91 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Ratings Stock AnalysisChartRatingsBuy This Stock Morningstar US Small Growth Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MSGR Aggregate RatingModerate Buy 2.61Holdings in MSGR have an aggregate rating of Moderate Buy based on 274 analyst ratings issued in the past year covering 21 companies (90.8% of the portfolio).MSGR Aggregate Price Target$13.91High Prediction$13.91Average Prediction$13.91Low Prediction$13.91Holdings in MSGR have an aggregate price target of $13.91 and a range of $13.91 to $13.91 covering 21 companies (90.8% of the portfolio).MSGR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Morningstar US Small Growth Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 MSGR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.06%VRTXVertex Pharmaceuticals$393.21-0.3%4.9235 of 5 stars2.57$496.05 26.2%28Positive News7.99%SCLXScilex$25.70-2.2%2.2115 of 5 stars2.50$455.00 1,670.4%4Positive NewsGap Up7.01%ARCTArcturus Therapeutics$18.13+4.7%3.0343 of 5 stars3.00$50.57 178.9%8Positive News6.62%ALNYAlnylam Pharmaceuticals$461.14-1.0%3.6887 of 5 stars2.85$421.28 -8.6%27Positive News6.44%MRNAModerna$23.88+1.6%4.5326 of 5 stars2.05$41.81 75.1%226.17%BNTXBioNTech$97.88+1.2%2.5277 of 5 stars2.76$135.80 38.7%175.97%SRPTSarepta Therapeutics$17.47+0.5%4.4253 of 5 stars2.07$39.32 125.1%29Positive NewsAnalyst Forecast5.78%PTCTPTC Therapeutics$58.98-3.5%3.8104 of 5 stars2.53$69.00 17.0%15Insider Trade4.94%MRVIMaravai LifeSciences$2.72+1.9%3.5377 of 5 stars2.18$5.22 91.9%11Positive NewsGap Up4.29%NTLAIntellia Therapeutics$11.57+1.3%4.4558 of 5 stars2.56$27.11 134.3%18Positive News4.24%IONSIonis Pharmaceuticals$61.10-3.3%3.8019 of 5 stars2.81$67.88 11.1%163.19%RNAAvidity Biosciences$40.22-10.1%2.1154 of 5 stars3.06$68.94 71.4%18Analyst Forecast3.19%CVACCureVac$5.36+0.4%3.9051 of 5 stars2.20$6.83 27.5%5Short Interest ↑3.18%ARWRArrowhead Pharmaceuticals$28.67-3.5%4.1529 of 5 stars3.00$43.14 50.5%8Analyst Revision2.95%ABUSArbutus Biopharma$4.53+1.6%1.8933 of 5 stars3.00$5.00 10.4%3News CoveragePositive News2.59%DYNDyne Therapeutics$12.86-2.2%3.9319 of 5 stars3.06$34.07 164.9%16Positive News2.10%SGMOSangamo Therapeutics$0.50-0.9%2.5225 of 5 stars2.67$4.50 799.5%6Positive NewsGap Up1.84%STOKStoke Therapeutics$23.40-0.3%3.9402 of 5 stars3.22$25.57 9.3%91.53%HLVXHilleVax$2.10+0.5%1.5945 of 5 stars2.00$2.00 -4.8%2Short Interest ↑1.52%PRQRProQR Therapeutics$1.99-9.1%2.6428 of 5 stars3.13$8.00 302.0%8News CoveragePositive NewsShort Interest ↑1.20%PEPGPepGen$1.59+7.4%2.8357 of 5 stars2.50$7.25 356.0%4 This page (NYSEARCA:MSGR) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Morningstar US Small Growth Please log in to your account or sign up in order to add this asset to your watchlist. Share Morningstar US Small Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MSGR Stock Alerts